Bringing the fundamentals into focus…
Back to Voyager Therapeutics, Inc.
How Voyager Therapeutics, Inc. stacks up
VYGR · against 454 other Healthcare companies listed in US-listed
Growth
10/ 100
Near the bottom of its peers.
Ranked #410 of 455 · scores higher than 10% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 10–19, including VYGR · Click a bar to see the companies
Why growth scores 10?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 98% of peers. 3-year revenue growth: -43.9% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 90% of peers. Revenue growth: -19.1% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = VYGR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VYGR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | -19.1% | 11.0% | 13% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | -43.9% | 11.0% | 3% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around VYGR| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 407 | 3.1B USD | 12 | 27 | |
| 408 | 1.2B USD | 11 | 6 | |
| 408 | 157M USD | 11 | ||
| 410 | 158M USD | 10 | 14 | |
| 410 | 113M USD | 10 | 23 | |
| 412 | 3.7B USD | 9 | 24 | |
| 412 | 5.7B USD | 9 | 38 | |
| 412 | 354M USD | 9 | 13 | |
| 415 | 3.7B USD | 8 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score